Skip to main content

Table 7 Positive blood culture and SeptiFast®: Isolated pathogens per patient with positive blood culture and positive SF result

From: Clinical impact of a commercially available multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis

Identified pathogen

Therapeutical relevance

Escherichia coli

No change: patient deceased before results became available, empirical therapy sufficient

Coagulase negative staphylococci

Modification necessary: Vancomycin added

Serratia marcescens

No change, empirical therapy sufficient

Staphylococcus aureus

No change, BC results leading to change were available before SF

Serratia marcescens

No change, empirical therapy started after sample collection sufficient

Enterococcus faecium

Modification necessary: Vancomycin added

Klebsiella pneumoniae

No change, empirical therapy sufficient

Candida tropicalis

No change, empirical therapy started after sample collection sufficient

Staphylococcus aureus

No change, empirical therapy sufficient

Proteus mirabilis

No change, empirical therapy sufficient

Enterococcus faecalis

No change, empirical therapy sufficient

Candida albicans

Modification necessary: Fluconazole added

Staphylococcus aureus

No change, empirical therapy sufficient

Escherichia coli

No change: patient deceased before results became available, empirical therapy sufficient